These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21193869)

  • 21. Application of receiver operating characteristic analysis to refine the prediction of potential digoxin drug interactions.
    Ellens H; Deng S; Coleman J; Bentz J; Taub ME; Ragueneau-Majlessi I; Chung SP; Herédi-Szabó K; Neuhoff S; Palm J; Balimane P; Zhang L; Jamei M; Hanna I; O'Connor M; Bednarczyk D; Forsgard M; Chu X; Funk C; Guo A; Hillgren KM; Li L; Pak AY; Perloff ES; Rajaraman G; Salphati L; Taur JS; Weitz D; Wortelboer HM; Xia CQ; Xiao G; Yamagata T; Lee CA
    Drug Metab Dispos; 2013 Jul; 41(7):1367-74. PubMed ID: 23620486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
    Neuhoff S; Ungell AL; Zamora I; Artursson P
    Pharm Res; 2003 Aug; 20(8):1141-8. PubMed ID: 12948010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P-glycoprotein as the mediator of itraconazole-digoxin interaction.
    Angirasa AK; Koch AZ
    J Am Podiatr Med Assoc; 2002 Sep; 92(8):471-2. PubMed ID: 12237270
    [No Abstract]   [Full Text] [Related]  

  • 24. In Situ intestinal perfusion of irinotecan: application to P-gp mediated drug interaction and introduction of an improved HPLC assay.
    Rabba AK; Si L; Xue K; Li M; Li G
    J Pharm Pharm Sci; 2011; 14(2):138-47. PubMed ID: 21733405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P-glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers.
    Wang X; Zhang ZY; Arora S; Hughes L; Wang J; Powers D; Christensen J; Lu S; Kansra V
    J Clin Pharmacol; 2018 Feb; 58(2):202-211. PubMed ID: 28906558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.
    Mayer U; Wagenaar E; Beijnen JH; Smit JW; Meijer DK; van Asperen J; Borst P; Schinkel AH
    Br J Pharmacol; 1996 Nov; 119(5):1038-44. PubMed ID: 8922756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
    Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y
    Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein.
    Lin JH
    Adv Drug Deliv Rev; 2003 Jan; 55(1):53-81. PubMed ID: 12535574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species difference in intestinal absorption mechanism of etoposide and digoxin between cynomolgus monkey and rat.
    Nishimura T; Kato Y; Amano N; Ono M; Kubo Y; Kimura Y; Fujita H; Tsuji A
    Pharm Res; 2008 Nov; 25(11):2467-76. PubMed ID: 18626752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-Drug Interactions of P-gp Substrates Unrelated to CYP Metabolism.
    Akamine Y; Yasui-Furukori N; Uno T
    Curr Drug Metab; 2019; 20(2):124-129. PubMed ID: 30280663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posaconazole-digoxin drug-drug interaction mediated by inhibition of P-glycoprotein.
    Shumaker AC; Bullard HM; Churpek J; Knoebel RW
    J Oncol Pharm Pract; 2019 Oct; 25(7):1758-1761. PubMed ID: 30259783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of expression/function of intestinal P-glycoprotein under disease states.
    Murakami T; Bodor E; Bodor N
    Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):59-78. PubMed ID: 31821048
    [No Abstract]   [Full Text] [Related]  

  • 33. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
    Tang F; Horie K; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.
    Katoh M; Nakajima M; Yamazaki H; Yokoi T
    Pharm Res; 2000 Oct; 17(10):1189-97. PubMed ID: 11145223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative evaluation of the function of small intestinal P-glycoprotein: comparative studies between in situ and in vitro.
    Adachi Y; Suzuki H; Sugiyama Y
    Pharm Res; 2003 Aug; 20(8):1163-9. PubMed ID: 12948013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.
    Becquemont L; Glaeser H; Drescher S; Hitzl M; Simon N; Murdter TE; Heinkele G; Hofmann U; Schaefer C; Burk O; Verstuyft C; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2006 May; 79(5):449-60. PubMed ID: 16678547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.
    de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
    J Pharm Sci; 2007 Oct; 96(10):2808-17. PubMed ID: 17542018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin.
    Stopfer P; Giessmann T; Hohl K; Sharma A; Ishiguro N; Taub ME; Zimdahl-Gelling H; Gansser D; Wein M; Ebner T; Müller F
    Clin Pharmacol Ther; 2016 Sep; 100(3):259-67. PubMed ID: 27256812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats.
    Suzuki K; Taniyama K; Aoyama T; Watanabe Y
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):385-392. PubMed ID: 32078103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes.
    Penzak SR; Shen JM; Alfaro RM; Remaley AT; Natarajan V; Falloon J
    Ther Drug Monit; 2004 Jun; 26(3):322-30. PubMed ID: 15167636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.